Abstract:Highlights • Bilayer mucoadhesive buccal films to enhance TA permeability through PermeapadTM. • F1-highest TA retention in PermeapadTM for potentially treating oral mucosa disorders. • EC backing layer minimized the loss of TA into the donor compartment. • The biomimetic membrane, PermeapadTM was successfully used for TA permeation assay. • Franz cell was used to predict the amount of drug permeating across PermeapadTM. Objectives The permeability of triamcinolone acetonide (TA), from bilayer mucoadhesive buccal films, through a biomimetic membrane, PermeapadTM, was investigated employing Franz diffusion cell. The delivery systems composition and ethyl cellulose (EC) backing layer, on drug permeability, were assessed. Methods Three TA-loaded films were tested; hydroxypropyl methylcellulose (HPMC K4M; bilayer [F1] and monolayer), HPMC K4M/Polyvinylpyrrolidone (PVP): 90/10 [F2], and HPMC K15M film [F3]. All films contained propylene glycol (PG-plasticiser). TA solution alone was used as a control. TA permeability via a PermeapadTM barrier, simulating buccal mucosa, was assessed over 8 h using a Franz diffusion cell. TA permeated into the receptor compartment, released in the donor compartment, and located on/within the PermeapadTM barrier were analysed using UV-spectrophotometer. Results 45.7 % drug retention within the PermeapadTM barrier was delivered from F1 (highest). F1, F2, and F3 significantly improved the TA's permeability through PermeapadTM, compared to TA solution alone (e.g., 8.5 % TA-solution, 21.5 %-F1), attributed to the synergy effect of HPMC and propylene glycol acting as penetration enhancers. F1 displayed a significant increase in drug permeability (receptor compartment; 21.5 %) compared to F3 (17.0 %). PVP significantly enhanced drug permeability (27.5 %). Impermeable EC backing layer controlled unidirectional drug release and reduced drug loss into the donor compartment (e.g., ∼28 % for monolayer film to ∼10 % for bilayer film, F1). Significance The mucoadhesive films demonstrated improved TA permeability via PermeapadTM. The findings suggest that these bilayer mucoadhesive films, particularly F1, hold promise for the effective topical treatment of oral mucosa disorders, such as recurrent aphthous stomatitis and oral lichen planus.

Triamcinolone acetonide release modelling from novel bilayer mucoadhesive films: an in vitro study

Permeability of triamcinolone acetonide, released from mucoadhesive films, through a buccal mucosa-mimetic barrier: PermeapadTM

Treating Recurrent Aphthous Stomatitis with Oral Mucoadhesive Films Containing Chitosan: a Clinical Random-Ized Controlled Study

Design and In Vitro/In Vivo Evaluation of Ultra-Thin Mucoadhesive Buccal Film Containing Fluticasone Propionate

Dissolving Microneedle Systems for the Oral Mucosal Delivery of Triamcinolone Acetonide to Treat Aphthous Stomatitis

Clinical evaluation of an oral mucoadhesive film containing chitosan for the treatment of recurrent aphthous stomatitis: a randomized, double-blind study

Preparation, in vitro and in vivo evaluation of chitosan-sodium alginate-ethyl cellulose polyelectrolyte film as a novel buccal mucosal delivery vehicle

Development of mucoadhesive patches for buccal administration of ibuprofen

α-Mangostin hydrogel film with chitosan alginate base for recurrent aphthous stomatitis (RAS) treatment: study protocol for double-blind randomized controlled trial

Quality by design approach for fabrication of extended-release buccal films for xerostomia employing hot-melt extrusion technology

Formulation and evaluation of buccal film of Ivabradine hydrochloride for the treatment of stable angina pectoris

A novel mucoadhesive film containing probiotic extract for oral candidiasis treatment: Formulation and antifungal evaluation

Customizable 3D Printed Implants Containing Triamcinolone Acetonide: Development, Analysis, Modification, and Modeling of Drug Release

Buccal films as a dressing for the treatment of aphthous lesions

A double-layer thin oral film for wet oral mucosa adhesion and efficient treatment of oral ulcers

Pressure-sensitive mucoadhesive polymer-based dental patches to treat periodontal diseases: an in vitro study

A novel lidocaine hydrochloride mucoadhesive films for periodontal diseases

Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability

Bioadhesive and drug-loaded cellulose nanofiber/alginate film for healing oral mucosal wounds

Formulation and Optimization of Sodium Alginate Polymer Film as a Buccal Mucoadhesive Drug Delivery System Containing Cetirizine Dihydrochloride

Tamarind seed polysaccharide-guar gum buccal films loaded with resveratrol-bovine serum albumin nanoparticles: Preparation, characterization, and mucoadhesiveness assessment